Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-23

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a generic ketorolac tromethamine product from Bionpharma Inc. (ANDA 216759) for short-term management of moderate to severe pain, including postope…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)